Ultimo aggiornamento :
19/11/2024
Beta-stimolante   Terbutaline sulfate  
Iniezione
Soluzione orale
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Baltic Malaysia
Betanyl Tunisia
Bricanyl Arabia Saudita, Australia, Austria, Colombia, Danimarca, Francia, Germania, Gran Bretagna, Irlanda, Islanda, Marocco, Norvegia, Svezia, Tunisia, Ungheria
Butal Messico
Terbasmin Spagna
Terburop Colombia
Terbutalina sulfato Colombia
Terbutaline sulfate Stati Uniti d’America
Bibliografia   Iniezione   Bibliografia : Terbutaline sulfate  
tipo pubblicazione
129 Rivista Smythe M, Malouf E.
Visual compatibility of insulin with secondary intravenous drugs in admixtures.
Am J Hosp Pharm 1991 ; 48: 125-126.
448 Rivista Mehta J, Searcy CJ, Jung DT.
Stability of terbutaline sulfate admixtures stored in polyvinyl chloride bags.
Am J Hosp Pharm 1986 ; 43: 1760-1762.
449 Rivista Glascock JC, DiPiro JT, Cadwallader DE, Perri M.
Stability of terbutaline sulfate repackaged in disposable plastic syringes.
Am J Hosp Pharm 1987 ; 44: 2291-2293.
1933 Rivista Gupta VD.
Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags.
Int J Pharm Compound 2004 ; 8, 5: 404-406.
3578 Laboratorio Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3597 Laboratorio Terbutaline sulfate (Bricanil®) - Summary of Product Characteristics
AstraZeneca 2013
3644 Laboratorio Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
4154 Laboratorio Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018

  Mentions Légales